Abstract Even the most innovative healthcare technologies provide patient benefits only when adopted by clinicians and/or patients in actual practice. Yet realizing optimal positive impact from a new technology for the widest range of individuals who would benefit remains elusive. In software and new product development, iterative rapidmethods more rapidly provide value, mitigate failure risks, and adapt to customer feedback. Co-development between builders and customers is a key agile principle. But how does one accomplish co-development with busy clinicians? In this paper, we discuss four practical agile co-development practices found helpful clinically: (1) User stories for lightweight requirements; (2) Time-boxed development for collaborative design and prompt course correction; (3) Automated acceptance test driven development, with clinician-vetted specifications; and (4) Monitoring of clinician interactions after release, for rapidcycle product adaptation and evolution. In the coming wave of innovation in healthcare apps ushered in by open APIs to EHRs, learning rapidly what new product features work well for clinicians and patients will become even more crucial.
I. INTRODUCTION
Even the most innovative healthcare technologies provide patient benefits only when adopted by clinicians and/or patients in actual practice. When developing a new technology or feature, how can we optimize clinician and patient initial adoption, and continue to adapt to their complex, evolving environment, in order to help achieve the greatest positive impact on health? In new product development, iterative rapidagile methods prove more effective than a traditional "waterfall" approach. Such products provide value earlier, mitigate risks sooner, and incorporate customer/user feedback to iteratively adapt and evolve, becoming more fit for real-world use. Agile methods should be equally applicable to innovative healthcare technology development projects. Co-development between builders and customers is one key agile concept for iteratively better meeting customer/user needs. But how does one accomplish co-development with busy clinicians, and adaptively develop products willingly adopted into their practices? In this paper, we propose 4 agile practices helpful clinically, and demonstrate their feasibility and usefulness.
A. Agile Methods for New Product Development
Since the publication of the Manifesto for Agile Software Development in 2001 [1] . Large-scale evidence now supports long-standing anecdotal support that such practices work better than traditional prescriptive project management approaches, across all sizes of software projects [3] . Agile methods work better than traditional waterfall development primarily in complex situations, where the optimal solution and product design is not knowable at the outset, and for new product development in general, not just software [4] , [5] . Agile methods have now been applied to EHR-based and other healthcare innovation [6] [7] [8] .
Co-development with customers is one of the core values in the Agile Manifesto ( One challenge in healthcare innovation is achieving -busy clinicians and with patients.
B. Agile Co-Development with Clinicians: 4 Practices
Collaborative co-development can be fostered by multiple techniques, not mutually exclusive, which can play complementary roles during product evolution. Four techniques potentially useful with clinicians include: Use Time-boxed development with available clinicians, for collaborative design, rapid feedback and early course correction [5] .
Automated acceptance test driven development, with clinicianand detailed specifications [10] .
Monitoring of clinician interactions after release, for rapid-cycle product adaptation and evolution [11] .
Though separate, the techniques offer synergies. For instance, short time-boxed iterations (1 or 2 weeks) become feasible through use of lightweight initial requirements, further elaborated through customer collaboration in creating automated acceptance tests as more detailed specifications. Also, adding automated acceptance tests to grow a regression -cycle In this paper, we use examples to empirically demonstrate feasibility and usefulness of these candidate practices.
II. METHODS

A. Location and Clinicians
All activities in this report took place at the University of Texas Southwestern Medical Center in Dallas, Texas. Clinicians involved in agile co-development were all faculty or house staff practicing in one of UT Southwester hospitals and clinics. This work was determined not to be human subjects research and not to require IRB oversight.
B. Procedures 1) User Stories
Lightweight initial feature requirements were elicited ype of user>, I want <something>, so that <benefit to be 12, 13] . The user stories were consistently written in the voice of the clinician or patient interacting with builder. That is, the <type of user> denotes the type of clinician or patient interacting with the feature, and the <benefit to be achieved> represents a benefit appreciated by that clinician or patient. For clinicians, this benefit was framed as directly to them (e.g. improved efficiency), to their patients (e.g. improved care, outcomes), and/or to their organization (e.g. improved financial stability). Most often development team members initially drafted the user stories, then validated and revised them in conversations with the feature customer and product owner. With experience, some product owners and customers began submitting new feature User Stories were elaborated with Acceptance Criteria as needed to unambiguously define what successful development of the feature would look like. Acceptance criteria were represented in the simplest possible way, commonly initially as bulleted lists, but occasionally augmented with more detailed specification formats and/or manual or automated acceptance tests (see Results).
2) Time-Boxed Iterations and Iteration Reviews
Two-week iterations were employed [5] , with enditeration reviews including demos of working product features developed during the iteration, attended by members of the team and by customers or their representatives. For clinician-facing features, clinician accessibility determined the iteration in which that user story would be scheduled, so the clinician(s) could clarify design issues during development, and provide clinical feedback at the enditeration demo and feature review. Agile modeling with customer collaboration was used selectively for detailed design decision-making during iterations [14, 15] 3) Automated Acceptance Test Driven Development Acceptance tests were written in table format, listing expected system output(s) for each specified set of inputs. Tables were constructed with reader-friendly terms, so that the specifications could be vetted with clinicians. Table- based tests were implemented in FitNesse (see Apparatus and Software) as part of automated testing suites [16] . Tests were started, then pass (turn green) in the development and testing environments once work was successfully completed [17] [18] [19] . Following release of the feature, the same test was added to the automated regression test suite for the production environment. Any subsequent failures of regression tests in production triggered a new entry in the incident management system for investigation and resolution.
4) Monitoring of Clinician Interactions
Clinician and patient interactions with EHR-based features are logged in our electronic health record, and available in standard relational database tables for querying and analysis. We constructed refreshable data cubes and graphical interactive displays of clinician interactions with EHR features (e.g. clinical decision support tools), for analysis of trends in clinician response and comparisons among sub-groups. Well-described iterative methods for development of dimensional models and analytics were employed [20, 21] . Analyses of clinician interactions were made available for decisions to adaptively evolve the configuration of EHR features, to retire features for ineffectiveness, and to broaden the scope of more effective feature configurations.
C. Apparatus and Software
User stories were documented initially on paper cards or as simple text files. For online management of many user stories and iterations across groups, we used agile project management software: CA Agile Central (formerly Rally), from Computer Associates. Automated testing employed the open-source testing software FitNesse, based on the Framework for Integrated Testing (Fit), along with the dbFit extension for querying databases [16, 22, 23] . Electronic health record software at UT Southwestern is from Epic (Verona, WI). Data querying, analysis, and presentation were performed with SQL Server, Analysis Services, and Power BI, all from Microsoft (Redmond, WA).
III. RESULTS / EXAMPLES
The following sections provide example applications of each of the four techniques, with several spanning development of a new clinical decision support (CDS) alert.
A. User Stories
and requirements remain relevant. User stories provide a lightweight way to elicit requirements, succinctly capturing More detailed acceptance criteria can be elaborated, even just-in-time prior to beginning development.
An example of a high-level user story for an entire EHRAs a physician caring for patients with kidney cancer, I want cancer including staging, recurrence, and/or progression, so that I can provide optimal clinical care to each individual patient, and continuously improve our overall care to this entire patient group.
Acceptance Criteria for the entire registry were initially component features envisioned as defining successful staged delivery of the product (Fig. 2) . Individual features were then elaborated with their own user stories. An example of a more detailed feature-level user story for a CDS alert to prevent spinal hematoma in patients with a post-surgical indwelling epidural catheter for pain control is:
As a hospital physician caring for post-operative patients, I want to be alerted when ordering an anticoagulant or antithrombotic medication for a patient with a post-operative epidural catheter, so that my patient avoids risk for developing a spinal hematoma and resulting neurologic impairment.
Acceptance criteria here are in the form of a bulleted list, co-formulated by the clinicians involved and the EHR team:
Alert fires for anyone with Order Entry privileges, in Hospital Encounters only (inpatient, observation, and ambulatory settings) It should query for EHR documentation of either presence of the epidural catheter OR any active medication ordered to infuse via epidural.
In those patients, it should then look for the presence of any anticoagulant except a) BID or TID 5000 units SQ heparin alone OR b) aspirin alone. If both of those two meds are present, however, still fire the alert.
It should then warn the provider ordering the anticoagulation that this form of anticoagulation is incompatible with an epidural catheter and direct them to contact the Pain Management Service.
B. Time-Boxed Iterations: Clinician Availability and Iteration Reviews
During 2-week iterations, the full cycle of detailed design, build, and test is performed, with a demo of working, tested features at end-iteration. Availability of the clinician enables detailed design questions to be addressed, helping ensure what is built is what is desired. In the case of the epidural alert, involvement of the clinician was crucial in getting the decision logic precisely correct for when to display the alert, given the discrete fields available in the EHR (Fig. 3) . 
C. Automated Acceptance Test-Driven Development
Creating detailed specifications in the form of testable serves multiple purposes, as: (1) detailed specifications of what should be built, (2) an automated acceptance test to confirm successful build, (3) part of a regression test suite to guard against unintended future changes, and (4) online documentation of the design. In acceptance test-driven development, tests initially fail before the feature is built, then pass when built successfully, as shown for the epiduralanticoagulation alert (Fig. 4 and Fig. 5 ). Automated acceptance tests during co-development with clinicians can be written to confirm the intended user interface design (e.g. wording, available actions) in addition to the underlying business/clinical logic. 
D. Monitoring of Clinician Interaction
Software is rarely perfectly fit for use upon first release, but the best software evolves over time to achieve maximal effectiveness. Monitoring and assessing clinician response to new products and features in production provides insights into what designs work best. Alerts are monitored for firing frequency (e.g. by provider type and setting), and clinician response choices when alerts are presented (Fig. 6 ). 
IV. DISCUSSION
Agile co-development holds promise for helping optimize clinician and patient adoption of innovative technologies, and fostering rapid-cycle adaptation to maximize value in practice. Our central finding is that 4 agile co-development techniques have proven feasible to engage clinicians in iterative feedback within the new product development cycle: user stories, time-boxed iterations with clinician demos of working features, automated acceptance testing, and monitoring of clinician real-world usage patterns.
The rise of standards-based open APIs (such as FHIR) for interacting with EHR data foretells a coming wave of innovation in healthcare apps and devices: learning rapidly what features work well for clinicians and patients (or not) will thus become even more crucial.
The goal of virtually all healthcare innovation is, at some Realizing optimal positive impact from new technologies for the widest range of individuals who would benefit remains elusive. Making progress means solving for increasing adoption of beneficial new features by appropriate patients and clinicians, and rapidly adapting to their needs. Practical agile co-development techniques can help.
